AzTrials
AzTrials

Prostheses DurabilityNCT07644689

Triple-Scan Protocol to Assess Passivity

A study testing Conventional Impression Technique, Digital Impression with Nonmodified Scan Body and Digital Impression with Modified Scan Body in people with Prostheses Durability, run by Mansoura University at 1 site in Egypt.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

Quantification and visualization the internal and marginal gaps by newer digital methods, such as the triple-scan protocol described by Borga Dönmez et al. (2024), employing 3D analysis software, offering a more objective and reproducible assessment. Read more about this study

Who is it for?
Ages 45 to 64 yearsHealthy volunteers can take part
Conditions the study is for
Prostheses Durability
What is being tested?
Conventional Impression Technique, Digital Impression with Nonmodified Scan Body and Digital Impression with Modified Scan Body
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
18 participants
Where
1 siteEgypt
Study dates
23 Apr 2023to 15 Feb 2025
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages 45 to 64 years
  • All sexes
  • Healthy volunteers accepted
  • Adult

Who may be able to join

  • Reduced patient satisfaction regarding the stability and retention of conventional mandibular dentures due to mandibular ridge atrophy.
  • Completely edentulous maxillary and mandibular arches for at least 1 year. Sufficient bone volume for placement of four mandibular implants without the need for bone grafting.
  • Age between 45 and 64 years. Ability and willingness to provide informed consent and comply with study procedures.

Who cannot join

  • Current smoking habit. Bone metabolic diseases that may affect osseointegration. History of radiotherapy to the head and neck region within the previous 3 years.
  • Systemic conditions or medications that could compromise implant healing. Inability to attend follow-up visits or comply with study requirements.

Trial locations and contacts

1 site in 1 country.

Egypt1 site
  • Alaa Mohamed Barakat Elazaly

    Al Mansurah

Other trials in Egypt

About this study

Official title: Triple-Scan Protocol for Evaluating Passivity of Complete-Arch Implant-Supported Fixed Prostheses: A Randomized Clinical Study

Quantification and visualization the internal and marginal gaps by newer digital methods, such as the triple-scan protocol described by Borga Dönmez et al. (2024), employing 3D analysis software, offering a more objective and reproducible assessment.

Being tested
Conventional Impression Technique, Digital Impression with Nonmodified Scan Body, Digital Impression with Modified Scan Body

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Conventional Impression TechniqueDevice

    Conventional implant impression using impression copings and elastomeric impression material.

  • Digital Impression with Nonmodified Scan BodyDevice

    Digital implant impression obtained using nonmodified implant scan bodies

  • Digital Impression with Modified Scan BodyDevice

    Digital implant impression obtained using subtractively modified implant scan bodies

Study groups in NCT07644689
Study groupRoleWhat they receive
Sequence AActive comparatorParticipants received the three impression techniques in the following order: Conventional Impression Technique Digital Impression with Nonmodified Scan Body Digital Impression with Modified Scan Body
Receives: Device: Conventional Impression Technique; Device: Digital Impression with Nonmodified Scan Body; Device: Digital Impression with Modified Scan Body
Sequence BActive comparatorParticipants received the three impression techniques in the following order: Digital Impression with Nonmodified Scan Body Digital Impression with Modified Scan Body Conventional Impression Technique
Receives: Device: Conventional Impression Technique; Device: Digital Impression with Nonmodified Scan Body; Device: Digital Impression with Modified Scan Body
Sequence CActive comparatorParticipants received the three impression techniques in the following order: Digital Impression with Modified Scan Body Conventional Impression Technique Digital Impression with Nonmodified Scan Body
Receives: Device: Conventional Impression Technique; Device: Digital Impression with Nonmodified Scan Body; Device: Digital Impression with Modified Scan Body

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. Mean horizontal misfit (µm)

    Mean horizontal misfit using the triple-scan protocol and STL file superimposition in software. Results will be reported in micrometers (µm).

    Measured: Day 1

  2. Mean vertical misfit (µm)

    Mean vertical misfit using the triple-scan protocol and STL file superimposition in software. Results will be reported in micrometers (µm).

    Measured: Day 1

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 Jun 2026
  2. Study start23 Apr 2023
  3. Primary completion3 Nov 2024
  4. Study completion15 Feb 2025

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Treatment
Allocation
Randomised
Intervention model
Crossover
Model description
Participants underwent all three impression techniques (conventional impression, digital impression with nonmodified scan bodies, and digital impression with modified scan bodies) in a randomized crossover sequence. Each participant served as his or her own control, and the order of impression techniques was randomized to minimize sequence effects.
Masking
Single blind
Who is masked
Participant
Enrolment
18 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT07644689
Sponsor's protocol ID
R.25.09.24
Status last verified
Jun 2026
First submitted
25 Nov 2025
Last updated
12 Jun 2026
Results posted
No
Data monitoring committee
No
FDA-regulated drug
No
FDA-regulated device
No

Questions about this trial

What is this clinical trial studying?

A study testing Conventional Impression Technique, Digital Impression with Nonmodified Scan Body and Digital Impression with Modified Scan Body in people with Prostheses Durability, run by Mansoura University at 1 site in Egypt.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 12 Jun 2026. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in Egypt. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

Mean horizontal misfit (µm) (time frame: Day 1). The study lists 2 primary outcomes in all. It is what the study was designed to measure, not a finding.

Where can I read the original study information?
Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 12 Jun 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in